A detailed history of Axxcess Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Axxcess Wealth Management, LLC holds 68,530 shares of BMY stock, worth $3.83 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
68,530
Previous 74,353 7.83%
Holding current value
$3.83 Million
Previous $3.85 Million 0.75%
% of portfolio
0.1%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

SELL
$51.92 - $59.94 $302,330 - $349,030
-5,823 Reduced 7.83%
68,530 $3.88 Million
Q3 2024

Nov 04, 2024

SELL
$39.66 - $51.75 $103,314 - $134,808
-2,605 Reduced 3.38%
74,353 $3.85 Million
Q2 2024

Aug 09, 2024

BUY
$40.25 - $52.99 $137,011 - $180,377
3,404 Added 4.63%
76,958 $3.2 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $643,603 - $729,721
13,414 Added 22.3%
73,554 $3.99 Million
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $755,560 - $901,592
15,585 Added 34.98%
60,140 $3.09 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $1.47 Million - $1.64 Million
25,403 Added 132.64%
44,555 $2.59 Million
Q2 2023

Aug 08, 2023

SELL
$63.71 - $70.74 $612,316 - $679,882
-9,611 Reduced 33.41%
19,152 $1.22 Million
Q1 2023

May 03, 2023

SELL
$65.71 - $74.53 $20,172 - $22,880
-307 Reduced 1.06%
28,763 $1.99 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $452,310 - $535,599
6,605 Added 29.4%
29,070 $2.09 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $35 - $21,054
-274 Reduced 1.2%
22,465 $1.6 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $156,859 - $172,756
2,160 Added 10.5%
22,739 $1.75 Million
Q1 2022

Aug 11, 2022

BUY
$61.48 - $73.72 $4,856 - $5,823
79 Added 0.39%
20,579 $1.5 Million
Q4 2021

Aug 11, 2022

BUY
$53.63 - $62.52 $1.1 Million - $1.28 Million
20,500 New
20,500 $1.28 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Axxcess Wealth Management, LLC Portfolio

Follow Axxcess Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axxcess Wealth Management, LLC with notifications on news.